Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
NCT00569283
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
BIOLOGICAL:
therapeutic allogeneic lymphocytes
Sponsor
Asan Medical Center